<DOC>
	<DOC>NCT02290028</DOC>
	<brief_summary>The QP ExCELs study is designed to confirm safety and efficacy of the BIOTRONIK Sentus OTW QP left ventricular leads to satisfy FDA requirements for regulatory approval of the leads in the US. Long-term safety of the BIOTRONIK Sentus OTW QP left ventricular leads will be confirmed during a post approval phase (US sites only).</brief_summary>
	<brief_title>Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Standard CRTD indication according to clinical routine De novo implantation or upgrade from existing ICD or pacemaker implant (with no prior attempt at LV lead placement) utilizing a BIOTRONIK CRTD system with IS4 LV port and Sentus QP LV lead Patient is able to understand the nature of the clinical investigation and provide written informed consent Patient is able and willing to complete all routine study visits at the investigational site Patient accepts Home Monitoring® concept Age ≥ 18 years Contraindication to CRTD therapy Currently implanted with an endocardial or epicardial left ventricular lead or had prior attempt to place a left ventricular lead Cardiac surgical procedure, such as coronary artery bypass graft, valve surgery, or ablation that is planned to occur within 6 months after implant (ablations planned to occur prior to or at implant are not exclusionary) Expected to receive a heart transplant or ventricular assist device within 6 months Life expectancy less than 12 months Participation in any other investigational cardiac clinical investigation during the course of the study Presence of another lifethreatening, underlying illness separate from their cardiac disorder Pregnant or breastfeeding at time of enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>CRT-D therapy</keyword>
	<keyword>quadripolar left ventricular lead</keyword>
</DOC>